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We describe a stromal predominant Wilms tumor with focal anaplasia and a complex, tumor
specific chromosome 11 aberration: a homozygous deletion of the entireWT1 gene within a
heterozygous 11p13 deletion and an additional region of uniparental disomy (UPD) limited
to 11p15.5-p15.2 including the IGF2 gene. The tumor carried a heterozygous p.T41A muta-
tion in CTNNB1. Cells established from the tumor carried the same chromosome 11 aberra-
tion, but a different, homozygous p.S45Δ CTNNB1mutation. Uniparental disomy (UPD)
3p21.3pter lead to the homozygous CTNNB1mutation. The tumor cell line was immortal-
ized using the catalytic subunit of human telomerase (hTERT) in conjunction with a novel
thermolabile mutant (U19dl89-97tsA58) of SV40 large T antigen (LT). This cell line is cyto-
genetically stable and can be grown indefinitely representing a valuable tool to study the
effect of a complete lack ofWT1 in tumor cells. The origin/fate of Wilms tumors withWT1
mutations is currently poorly defined. Here we studied the expression of several genes
expressed in early kidney development, e.g. FOXD1, PAX3, SIX1,OSR1,OSR2 andMEIS1
and show that these are expressed at similar levels in the parental and the immortalized
Wilms10 cells. In addition the limited potential for muscle/ osteogenic/ adipogenic differenti-
ation similar to all otherWT1mutant cell lines is also observed in the Wilms10 tumor cell line
and this is retained in the immortalized cells. In summary theseWilms10 cells are a valuable
model system for functional studies ofWT1mutant cells.
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Introduction
Wilms tumor (WT), a malignant childhood neoplasm of the kidney, is thought to arise from
embryonic renal mesenchyme with impaired nephrogenic differentiation potential. Most
tumors have a mixed histology, containing blastema, epithelia and stroma. In the WT variant
with a predominating stromal component, heterotypic cells, such as rhabdomyoblasts, fat, car-
tilage and bone can be found, not normally present in the kidney and likely to be derived from
abnormal mesenchymal differentiation. Constitutional or somatic mutations in theWT1 gene
are found in most stromal-type tumors, often associated with mutations in the CTNNB1 gene
[1–5].
Intralobar nephrogenic rests (ILNR) occurring early in kidney development can be found as
precursor lesions inWT1mutant tumors [6]. Microdissection of ILNRs inWT1mutant Wilms
tumors revealed that these carry biallelicWT1mutations but no CTNNB1mutations, whereas
the associated tumor cells had CTNNB1mutations [7]. MostWT1mutant tumors have addi-
tional mutations in CTNNB1 orWTX, highlighting the importance of activated WNT signaling
in tumors with inactiveWT1 [2,5,8]. The presence of activating mutations in CTNNB1 or
WTX suggests that the functional loss ofWT1 poses a strong selection pressure for additional
mutations. This is further supported by our previous description of a patient with a germ line
WT1mutation who developed four tumors with different CTNNB1mutations, suggesting their
independent origin and/or tumor heterogeneity. In addition the same tumor harbored different
CTNNB1mutations in different histological areas [9] (unpublished observation). In these
Wilms tumors three “hits” occurred; the first is a germ lineWT1mutation, the second is the
loss of heterozygosity (LOH) in 11p, resulting in loss of theWT1 wild type allele and the third
is a CTNNB1mutation [9].
Most cell lines that we have established fromWT1mutant Wilms tumors have additional
CTNNB1mutations and theWT1mutation is either homozygous due to a mitotic recombina-
tion event or the cells have a deletion on one allele and a mutation in the other allele. TheWT1
gene is still present in all cell lines and theoretically a mutant RNA encoding a mutant protein
can be synthesized. Indeed, we have recently shown that mutant WT1Wilms3 protein with a C-
terminal extension (p.V432fsX87) exhibits gain of function properties. The mutant protein has
lost the wild type WT1 function for sequence specific DNA binding, but facilitates the expres-
sion of genes regulating the cell cycle [10]. Therefore this mutant WT1 protein has not only
lost its wild type function but has also gained a new function. It is of interest that Wilms3 cells
do not carry a mutant CTNNB1 gene; the gain of function of the mutant WT1 protein in regu-
lating the cell cycle could explain, why these cells do not need additional mutations in
CTNNB1 norWTX [10].
All our previously establishedWT1mutant Wilms tumor cell lines have a limited life span,
similar to normal human mesenchymal stem cells (hMSC). Under in vitro growth conditions
they can be cultivated at most for 60 population doublings. Primary cells in culture as well as
some tumor cells have a limited life span that limits their use for experimental manipulation.
Most biochemical and genetic studies require large cell numbers. Therefore, immortalized cell
lines would be very useful for such studies. It has been described that the life span of normal
human cells can be extended by introduction of the catalytic subunit of telomerase (TERT)
[11]. More recent reports suggested that for a successful immortalization of human cells addi-
tional factors are needed. In many cases a temperature sensitive (ts) SV40 large T antigen (LT)
was used resulting in conditionally immortalized cells. Successful immortalization using ts LT
in combination with hTERT was described for many different normal cell types, for example
glomerular mesangial cells, glomerular endothelial cells, podocyctes, mammary fibroblasts and
endothelial cells, airway epithelial cells and hepatocytes [12–17]. All these normal cells did not
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proliferate at 37°C, the nonpermissive temperature of the tsLT, indicating that for their immor-
talization the LT is mandatory.
Here we describe a stromal type Wilms tumor with a homozygous deletion ofWT1 nested
within a heterozygous 11p13 deletion and a CTNNB1mutation. Genetic analyses of cells
derived from the Wilms tumor (Wilms10) showed the sameWT1/11p13 alteration but a differ-
ent mutation in CTNNB1 as compared to the bulk tumor DNA. aSNP/CGH revealed UPD in
3p and 11p15 not extending to theWT1 gene. Through immortalization of this cell line with ts
LT and hTERT, we have established the first Wilms tumor cell line with a homozygous deletion
of the entireWT1 gene, resulting in a complete lack ofWT1. This immortalized Wilms10 cell
line should be useful for further exploration of the effect ofWT1 loss in genetic and biochemi-




A 2 year-old girl presented with an isolated left renal mass. The tumor was surgically removed
upfront and the histology showed a triphasic stromal predominant Wilms tumor with focal
anaplasia and p53 over-expression in these anaplastic foci (S1 Fig). The tumor infiltrated the
renal capsule, the renal sinus, but did not invade the vessels or the ureter. Regional lymph
nodes had no evidence of tumor. Procedures were approved by the Institutional Review Board
(IRB) at Hospital Sant Joan de Déu (Barcelona, Spain) and are in accordance with the princi-
ples expressed in the Declaration of Helsinki. Written informed consent was obtained from
parents. Tumor material necessary for histologic and molecular diagnosis was obtained from
the tumor before a portion was processed for research purposes, following Standard Operating
Protocols at the Department of Pathology.
Mutation analysis
Tumor DNA was isolated directly from a piece of solid tumor tissue. DNA from blood and cell
culture cells was isolated by standard methods. The completeWT1 gene and CTNNB1 exon3
was analyzed as described before [5].
P53 mutation analysis was done by Next-generation pyrosequencing using 454 Titanium
Amplicon chemistry (Roche Applied Science, Penzberg, Germany) according to the manufac-
turer's instructions (8 amplicons, Transcript-ID ENST00000269305). Primer sequences and
PCR conditions were kindly provided by A. Kohlmann (MLL, München). Sequencing run of
the TP53 gene was carried out on a GS Junior System instrument (Roche Applied Science). All
sequencing data were generated using the Junior Sequencer Instrument software version 2.7
(Roche Applied Science). Sequence alignment and variant detection were performed using the
GS Amplicon Variant Analyzer software version 2.7 (Roche Applied Science).
Cell culture and establishment of immortalized cells
The tumor was finely minced and a cell culture was established using MSCG medium as
described [18]. According to our nomenclature of cells established from stromal-predominant
Wilms tumors, this cell culture was called Wilms10.
To establish an immortalized cell line, the catalytic subunit of human telomerase (hTERT,
pBABE-hygro-hTERT, Addgene 1773) [19] and a novel triple mutant SV40 LT (U19dl89-
97tsA58) was introduced into primary Wilms10 cells via retroviral infection as described [15].
The triple mutant is a combination of three SV40 early region mutations: U19, prevents T
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antigen from binding SV40 origin like DNA sequences [20]; dl89-97, a deletion of amino acids
89–97 that prevents binding to Bub1 [21]; and tsA58, that confers thermolability [22,23]. It
was prepared by replacing an early region fragment encompassing the dl89-97 mutation and
the large T antigen splice junction within pZipSVU19tsA58 early region to generate the novel
thermolabile triple mutant LT antigen cDNA (PA and PSJ, unpublished)[15]. The pZip-
NeoU19dl89-97tsA58 was used to derive a stable amphotropic TEFLY-A producer cell line as
described previously (PA and PSJ, unpublished)[15]. Amphotropic viruses prepared from the
stable producer cells for tsLT and hTERT from a triple transfected HEK293FT cell line were
mixed and used to transduce the primaryWilms 10 cells. After infection, the cells were cultured
in G418 (selection for tsLT, 200 μg/ml) for 1 week, followed by hygromycin (selection for
hTERT, 20 μg/ml) for another week to select for successfully doubly transduced cells. Single cell
clones were isolated and cultivated at 33°C initially to maintain the active form of the tempera-
ture sensitive LT. After the first confluence, clones were split and cultured at 33° and 37°C. One
immortalized clone was selected for further studies and was named imWilms10. The imWilms10
cells continued to grow at 37°C, whereas normal hMSC immortalized with the same genes did
not continue to proliferate at 37°C. The imWilms10 cells were continuously cultured in medium
with alternating hygromycin and G418 for one week each, with a break of selection for one week.
SNP/CGH array analysis and custom array
The SNP/CGH array (aSNP/aCGH) analysis of the primary tumor and the tumor cell culture
from patient Wilms10 was performed using a 2x400K oligonucleotide microarray (Sure Print
G3 Human Genome CGH + SNPMicroarray; Agilent Technologies Alto, CA, USA). With this
array format, copy number changes, as well as copy neutral aberrations, such as uniparental
disomy (UPD) can be detected on the same array. The samples were prepared and labeled as
described by the manufacturer (Protocol Version 7.3 March 2014). To detect uniparental dis-
omy (UPD), a female gender reference DNA (NA12878, Coriell Institute, USA) has to be used
as control. To quantify the array data the feature extraction module of Agilent's CytoGenomics
software (Version 1.5.1.0) was used and, for visualization, CytoGenomics Version 2.0.6.0.
To determine the breakpoints of the homozygousWT1 and heterozygous 11p13 deletion, a
high-resolution array was designed (http://earray.chem.agilent.com/earray/). The region of the
homozygousWT1 alteration was covered with oligonucleotides at a distance of 100 bp, whereas
the probes for the heterozygous deletion had a spacing of 300 bp.
Protein analysis
For the analysis of tsLT and MEST, proteins were extracted from the cells using RIPA buffer
(150mMNaCl, 1% NP40, 0.5% DOC, 0.1% SDS, 50 mM Tris (pH8.0)), separated by SDS-PAGE
and transferred to a PVDFmembrane. The blot was incubated with a monoclonal antibody
against SV40 LT (MAb423) or a monoclonal antibody against MEST (Abcam, 151564).
For the simultaneous analysis of the phosphorylation status of 49 tyrosine kinase receptors
a ProteomeProfilerTM antibody array was used. Proteins fromWilms10 and imWilms10 cells
cultured at 33°C were extracted and incubated with the antibody arrays as described by the
manufacturer (R&D systems).
Differentiation analysis
Adipogenic and osteogenic differentiation was analyzed using reagents from Lonza and as
described by the manufacturer. hMSC cells were used as controls in the same experiments.
Non-induced control cells were kept in the respective maintenance media. After a 3 week
induction and a maintenance phase, cells were processed for adipogenic differentiation by
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staining with Oil Red O. In addition cells were cultured for 10 days in the induction and main-
tenance medium for adipogenesis and total RNA (RNeasy, Qiagen) was extracted at day 0 and
10 for Q-RT-PCR analyses. Assay on Demand for PPARG (Hs01115513_m1, Life technologies)
was used for the analysis of adipogenesis [24]. Immortalized cells were cultured in the differen-
tiation medium for 18 days before RNA isolation.
For osteogenic differentiation cells were harvested after 19 days of differentiation by scrap-
ing them in the presence of 0.5M HCl and a calcium Liquicolor assay was performed according
to the manufacturers instructions (Stanbio Laboratory, USA).
Myogenic differentiation was induced with DMEM/F12 (Gibco) supplemented with 2% horse
serum for 12 days and HSMM cells were used as controls. For immunofluorescence analysis cells
were seeded in four chamber slides (BD Biosciences) and after growth in induction or control
medium for 9 days, cells were stained with a Titin-specific antibody as described before [18].
Gene expression analysis
For gene expression analyses total RNA was isolated from the Wilms10 tumor cell line and the
immortalized cells (imWilms10) cultured at 33°C using the RNeasy Mini Kit (Qiagen). RNA
from two biological replicates was analyzed in all gene expression experiments. RNAs were
labeled in the One-Color format as described by the manufacturer (Agilent Technologies) and
hybridized to 4x44K”Whole Human Genome Oligo Microarrays (V1, Agilent)" in the presence
of “Spike-In positive controls” (Agilent). The microarray scans were quantified using Agilent
Feature Extraction Software (V10.1.1.1). Basic statistical analyses were performed within the 'R'
statistical computing environment (R Development Core Team, 2011). The R-library 'Limma'
[25] Bioconductor (www.bioconductor.org) was used for quantile normalization of microar-
rays [26]. To compare primary and immortalized cells, gene expression data were first filtered
for genes showing a minimal intensity of 200 in at least one channel. Statistical significance
of single genes was determined using Limma's moderated t-test, with a significance level of
0.1 applied to the FDR adjusted p-values. Additionally, only genes showing an absolute fold
change of>1.5 were considered relevant. For further less stringent comparisons, e.g. pathway
analyses not requiring all genes involved to show a significant differential expression we
extended our gene selection to include genes with a raw p-value of up to 0.05, same expression
and fold change cut-off as above. Gene expression data can be found at GEO: GSE 71265
For Q-RT-PCR analyses cDNAs were synthesized using TaqMan Reverse Transcription
Reagents (Applied Biosystems). The Q-RT-PCR experiments were performed in triplicates using
the TaqMan gene expression assay probes from Applied Biosystems forWT1 (Hs00240913_m1)
and IGF2 (Hs01005963_m1) with Brilliant II QPCRMaster Mix with Low Rox (Agilent Technol-
ogies). The expression levels were normalized with RER1 (Hs00199824_m1) RNA. The reason
for using RER1 as calibrator was that this gene was basically never regulated in any of our gene
expression studies. The Q-RT-PCRs experiments were run on a Mx3000P Sequence Detection
System (Stratagene). Statistical significance of the normalized Ct values (ΔCt) was assessed by a
t-test.
Results
WT1 analysis and aSNP/CGH
Using DHPLC and DNA sequencing, no pathogenic mutation ofWT1 was found in blood or
tumor DNA. Multiple-ligation probe analysis (MLPA,) did not identify copy number varia-
tions in the blood DNA (Fig 1A), whereas the tumor DNA carried a homozygous deletion of
theWT1 gene (Fig 1B). This result suggests that the tumor DNA preparation contained some
DNA from normal cells that resulted in a wild-typeWT1 DNA sequence. In contrast, by using
Conditionally ImmortalizedWilms Tumor Cell Line with a HomozygousWT1 Deletion
PLOS ONE | DOI:10.1371/journal.pone.0155561 May 23, 2016 5 / 22
Conditionally ImmortalizedWilms Tumor Cell Line with a HomozygousWT1 Deletion
PLOS ONE | DOI:10.1371/journal.pone.0155561 May 23, 2016 6 / 22
MLPAwe did not detect amplification of contaminating normal DNA, except for one small peak,
corresponding to exon10 ofWT1. The peak for a neighboring gene,HIPK3was reduced, suggesting
a heterozygous deletion (Fig 1B, red arrow). This indicates that the patient had a tumor specific
homozygousWT1 deletion and a heterozygous deletion extending at least to theHIPK3 gene.
To study the deletion in more detail a combined aSNP/aCGH analysis was performed with
DNA isolated from the tumor, co-hybridized with reference control DNA to detect copy num-
ber imbalances. This analysis revealed that the homozygous deletion was restricted to theWT1
gene and a few neighboring oligonucleotides with a size of 228kb (log ratio>4) (Fig 1C). The
heterozygous deletion had a size of 1.05 Mb and encompasses the genes EIF3M, CCDC73,
PRRG4, QSER1, DEPDC7, TCP11L1, CSTF3 and HIPK3. In addition, two deleted segments
were identified on chromosome 1p32p32.1 with a maximal size of 3.2 Mb (57288535–
60440170) and a smaller deletion at 1p31.1 with a maximal size of 203kb (74946777–
75185022) (S2A and S2B Fig). Furthermore, two UPD regions could be identified with this
array format; one limited to 11p15.3pter containing IGF2, but not extending to theWT1 gene
(219089–13058405, 12.8Mb) (Fig 1E and S3 Fig) and another one at 3p21.3pter (107994–
49449638, 49.3Mb), the interval where the CTNNB1 gene is located (S4 Fig).
DNA from the established tumor cell line (Wilms10) was also analyzed with aCGH/aSNP
and the same 11p13 heterozygous/homozygous deletion was identified (Fig 1D). A cytogenetic
analysis of the tumour cell culture showed a normal karyotype, 46, XX (not shown), indicating
that the 1 Mb deletion in 11p13 and the 3.2 Mb deletion in 1p32.2p32.1 is below the cyto-
genetic detection limit.
A custom array covering the heterozygous/homozygous deleted 11p13 segment at a high
density revealed the start and endpoint position of the heterozygous/homozygous deletions in
the tumor and the established Wilms10 tumor cell line (S5 Fig). Fig 1F shows an overview of
the exact deletion on chromosome 11p13. Taken together the tumor contained a complex and
unusual abnormality of chromosome 11 with a region of UPD restricted to 11p15 and a homo-
zygous deletion restricted to theWT1 gene within a heterozygous 11p13 deletion. The derived
cell culture harbored the same alterations as the tumor sample.
As this is the first cell line with no genomic DNA covering theWT1 gene it was of interest
to compare the level ofWT1 gene expression in the cell lines with the differentWT1mutations
versus the Wilms10 cell line. The genetic characteristics of all established cell lines is shown in
S1 Table. As expected the Q-RT-PCR analysis showed that Wilms10 cells do not express any
WT1mRNA and that the level varies between cell lines with the lowest, almost undetectable
level in Wilms1 cells and the highest level in Wilms3 (Fig 2). It will be interesting to explore the
difference in gene expression profiles between the different WT cell lines depending on the
level ofWT1 in future studies but this is not within the scope of this work.
CTNNB1 and TP53 analysis
The primary tumor harbored a heterozygous c.121A>G/p.T41A CTNNB1mutation (Fig 3A),
whereas the Wilms10 tumor cell culture carried a homozygous deletion of three nucleotides
Fig 1. Characterization of the chromosome 11p13 alteration in tumor and tumor cell culture DNA from patient Wilms10. (A) Multiplex
ligation-dependent probe amplification analysis (MLPA) of blood DNA. Green peaks are derived fromWT1 exons, white peaks represent genes
proximal ofWT1 in 11p13, purple peaks correspond to PAX6 and pale pink peaks to BDNF exons, distal ofWT1 in 11p13. The yellow peaks
represent 11p15 markers and blue peaks are controls from different chromosomes. (B) In DNA isolated from the primary Wilms10 tumor; only one
small peak from exon 10 ofWT1 is observed, whereas all other products fromWT1 are missing entirely. A red arrows indicates the reduced peak
from theHIPK3 gene. (C) aSNP/aCGH data of the 11p13 region from the primary Wilms tumor and (D) from the tumor derived cell culture. The
homozygous deletion covering theWT1 gene is clearly visible with log ratio of -4. (E) UPD limited to 11p15 as shown with the cytogenomics
workbench program. (F) Summary of the genomic alterations in 11p13 with the positions of the heterozygous and homozygous deletions.
doi:10.1371/journal.pone.0155561.g001
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c.133-135 del TCT, leading to loss of amino acid S45 (p.S45Δ) (Fig 3B). The p.T41A CTNNB1
mutation identified in the tumor specimen was not seen in the cell culture. As cultured tumor
cells have two copies of chromosome 3 (data not shown) and UPD of 3p (Fig 3C) this indicates
Fig 2. Quantitative RT-PCR analysis of theWT1 expression in variousWT cell lines. Total RNA from the
WT1mutant cell lines Wilms1, Wilms2, Wilms3, Wilms8 andWilms10 was analyzed by Q-RT-PCR. The
genetic alterations present in these cell lines are found in S1 Table. The expression level was normalized
versus RER1, a gene with the lowest variation between the cell lines in our gene expression studies. The
analysis was performed in triplicates. The error bars correspond to 95% confidence intervals. The relative
expression is shown versusWilms3.
doi:10.1371/journal.pone.0155561.g002
Fig 3. Comparison of CTNNB1mutations and UPD region on chromosome 3 in the primaryWilms10 tumor and tumor-derived cells. (A)
DNA sequencing reveals a heterozygous A>G CTNNB1mutation at position c.121/p.T41A in the primary Wilms10 tumor. The position of the three
deleted nucleoties in the tumor cells culture are boxed. (B) identification of a homozygous deletion c.133_135del TCT (p.S45Δ) in the CTNNB1 gene
in theWilms10 tumor-derived cell line. The position of this deletion is indicated above the DNA sequence. (C) UPD region on chromosome 3p as
shown with the cytogenomics workbench program.
doi:10.1371/journal.pone.0155561.g003
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that the homozygous p.S45Δmutation in the cell culture is the result of a mitotic recombina-
tion with loss of the normal CTNNB1 allele and duplication of the mutant allele. These two dif-
ferent mutations in the tumor specimen and the tumor cell line point to tumor heterogeneity.
Furthermore as the tumor and the cell line have the sameWT1 alteration but different
CTNNB1mutations this supports the model that theWT1 alteration occurs first, with a high
selection pressure to acquire mutations in CTNNB1.
No mutation was identified in TP53 in the tumor DNA nor in the tumor cell culture DNA.
However, DNA from the anaplastic focus was not available and a mutation might be present in
these cells (S1 Fig).
Immortalization of Wilms10 and characterization of imWilms10 cells
All established Wilms tumor derived cell lines from tumors withWT1mutations as well as
Wilms10 cells have a limited in vitro growth potential. Therefore we wished to immortalize
Wilms10 cells with the homozygousWT1 deletion using a tsLT in conjunction with human tel-
omerase (hTERT) enabling their long term passaging. For this purpose an expression construct
encoding a novel triple mutant of LT (U19dl89-97tsA58) was used; this mutant T antigen does
not bind to ori-like DNA sequences, does not bind BUB1 and is thermolabile [20,21,23]. When
this mutant tsLT was used in conjunction with an expression construct encoding hTERT,
immortalized cells were readily established and these were termed "imWilms10". The cells were
cultured so far for more than 30 passages, corresponding to 90 population doublings. Cyto-
genetic analyses of immortalized cells revealed a normal karyotype (not shown). The immortal-
ized cell line remained cytogenetically normal for many passages, possibly due to the deletion
of the amino acids responsible for BUB1 binding [21,27]. aCGH showed that the immortalized
cells harbor the same heterozygous/homozygous 11p13 alteration with a complete loss ofWT1
and the two deletions on chromosome 1 (not shown).
To demonstrate that the tsLT protein is expressed in these cells, they were cultured at 33°
(permissive temperature) and 39°C (nonpermissive temperature) and protein was extracted
from these cells. Although the tsLT construct encoded a ts mutant protein a low level was
detected at 39°C (S6A Fig). Sequencing of the tsLT insert revealed the correct presence of the ts
mutation in the LT gene (PSJ, not shown). Similar observations were made in other immortal-
ized WT cells using the same T antigen construct (unpublished Görldt, Tenbusch and BR-P).
hTERT expression in these cells was verified by RT-PCR (S6B Fig).
In order to evaluate the effect of the immortalization process of Wilms10 cells by hTERT
and tsLT we established gene expression profiles of cells cultivated at 33°C where both genes
are active (permissive temperature for tsLT) using Agilent whole genome microarrays. It was
the aim of this experiment to investigate the impact of the expression of these two genes on the
transcriptome of Wilms10 tumor derived cells. This information shows whether the “biology”
of immortalized (imWilms10 cells) is affected. However, it should be noted that 33°C is a non-
physiological temperature for human cells and they grow very slowly at that temperature. First
we compared the expression levels of selected genes that are expressed in early kidney develop-
ment and/or different compartments of the kidney [28]. These genes are also expressed in the
otherWT1mutant cell lines [18]. For example, FOXD1 is typically expressed in stromal cells
and also in allWT1mutant tumor derived cell lines we have established previously. Fig 4
shows that Wilms10 and imWilms10 cells express similar levels of FOXD1mRNA. Likewise
PAX3 is expressed in stromal cells and ectopically in WT with a myogenic histopathology [29].
High expression levels are found in ourWT1mutant cell lines [18] and in Wilms10 and
immortalized imWilms10 cells (Fig 4). The expression levels of genes involved in early kidney
differentiation e.g.MEIS1, OSR1, OSR2 and SIX1 [28] are not affected by tsLT and hTERT
Conditionally ImmortalizedWilms Tumor Cell Line with a HomozygousWT1 Deletion
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expression (Fig 4). Likewise expression levels of kidney specific genes SYNPO, CD2AP, NES
and genes associated with active Wnt signaling like CTNNB1 and AXIN1 are similar in
Wilms10 and imWilms10 cells (Fig 4). We conclude that tsLT and hTERT dependent immor-
talization does not affect the expression of these characteristic kidney marker genes in
Wilms10 cells.
We next investigated the impact of the immortalization process by analyzing differentially
expressed genes using Wilms10 cells as control. First, we analyzed differentially expressed
genes using stringent parameters (FDR q< 0.1) and an absolute fold change> 1.5. Under
these conditions we detected 270 genes with higher and 212 genes with lower expression levels
in imWilms10 cells. To gain insight into the function of these genes we used the MetaCore
algorithm “enrichment of pathway maps”. The 10 most significant pathway maps are shown in
Fig 5. In the down-regulated gene set (Fig 5A) the pathway map “Development_Hedgehog and
PTH signaling pathways in bone and cartilage development” is most significant. Fig 6 shows
this pathway map and the down-regulated genes are indicated by blue bars. For example, from
this pathway genes encoding PTHR1 and PTCH1 receptors as well as downstream genes GLI1
and PRKAR1A (PKA-reg (cAMP-dependent)) are down-regulated in imWilms10 cells (Fig
6B). A complete list of>10 fold down-regulated genes is shown in S2 Table. We noted a down-
regulation of IGF2 (-214 fold, FDR p = 0.0141) andMEST (-45 fold, FDR p = 0.0117). The
strong down-regulation of IGF2 was confirmed by Q-RT-PCR (Fig 7A) and the down-regula-
tion ofMEST RNA and corresponding repression of the MEST protein is shown in Fig 7B.
Other highly down-regulated genes encode transcription factors involved in early develop-
ment, e.g. SALL1,MAF, PBX4, and EYA2. In the up-regulated gene set the "Retinol metabo-
lism" and "Transcription_CoREST complex-mediated epigenetic gene silencing" are most
significant (Fig 5B). A complete list of up-regulated genes (<10 fold) is shown in S3 Table.
When less stringent conditions were applied to gene expression analysis, fc> 1.5 and a raw
p-value< 0.05, we identified significantly enriched pathway maps using the data set of up-reg-
ulated genes. These include “Cell cycle_Start of DNA replication in early S-phase” and “DNA
damage_ATM/ATR regulation of G1/S checkpoint”. HereHistone H1C, BARD1, CDC7,
CCNE1,MCM3 and CCNA1 gene expression levels were strongly induced in imWilms10 cells
(S8 Fig). In this context it is important to note that LT interacts with p53 and pRB, enabling
the cells to bypass a cell cycle control checkpoint (restriction point). This explains why cell
Fig 4. Similar expression level of selected kidneymarker genes in imWilms10 andWilms10 cells. The selection of these genes was
based on studies of gene expression in various compartments during kidney development. All of these genes are also expressed in the other
WT1mutant cell lines that we have previously established. The data are derived frommicroarray analyses of two biological replicates. The
expression level is indicated frommicroarray intensity and the bar represents standard error.
doi:10.1371/journal.pone.0155561.g004
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proliferation proceeds even at later passages. However, the interpretation of these less stringent
differential gene expression data should be viewed with caution. In summary the gene expres-
sion data confirm that imWilms10 cells have an extended proliferation capacity in comparison
to Wilms10 cells.
MetaCore analysis using the data set of down-regulated genes revealed an enrichment of
pathway maps and the ten most significant maps are shown in S9 Fig. For example the pathway
map “Development-Regulation of epithelial to mesenchymal transition (EMT)” is highly sig-
nificant. Several down-regulated genes of this pathway encode receptors for example PDGFRA,
PDGFRB, TGFBR1, TGFBR2, EDNRA and EDNRB. In addition, the expression of genes encod-
ing receptor ligands and downstream signaling components are down-regulated in imWilms10
cells. These include BMP2 and BMP4 (S10A Fig) andWNT16, ERK1/2, SMAD4,MAPK14,
RPS6KA2, SNAI2, ZEB2 and TWIST1. Another important result is the down-regulation of sev-
eral genes from the Wnt signaling pathway. These genes predominantly encode negative
Fig 5. Comparison of gene expression of the imWilms10 cells cultured at 33° C with non immortalized
Wilms10 cells. The data set of differentially expressed genes was analyzed with the MetaCore algorithm
"pathway analysis" to identify significantly enriched pathways. In this analysis the differentially expressed
gene set of up- and down-regulated genes were analyzed separately (FDR adjusted p-value of 0.1). (A) the
top 10 enriched pathways for down-regulated genes. The log P-values are indicated above the list. (B) the top
10 enriched pathways for up-regulated genes.
doi:10.1371/journal.pone.0155561.g005
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regulators of Wnt signaling e.g. AXIN2, NKD2, SFRP2 and the transcriptional corepressor
TLE1 (S10B Fig). Furthermore, we detected strong down-regulation of ROR1 and ROR2 genes
from the noncanonical Wnt signaling pathway.
Fig 6. The top pathway down-regulated in imWilms10 versus non immortalizedWilms10 cells. (A) Using a gene set derived from
the stringent parameters (FDR adjusted p-value of 0.1) the top down-regulated pathway in imWilms10 is Development_Hedgehog and
PTH signalling pathways in bone and cartilage development". Down-regulated genes from this pathway are labelled with a thermometer.
The height of the blue colour in the thermometer shows the fold down-regulation in the immortalized cells. (B) shown is the down-
regulation of the four genes mapping to this pathway by expression intensity on the biological replicates on the arrays.
doi:10.1371/journal.pone.0155561.g006
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To study whether the down-regulation of genes encoding receptors has functional conse-
quences we investigated their phosphorylation status using human Phospho-RTK-proteome
profiler arrays. Here phosphorylation levels of 49 receptors can be detected simultaneously.
The results are shown in Fig 8A. Both, PDGFRA and PDGFRB show reduced phosphorylation
levels in imWilms10 cells. In addition, IGF-IR phosphorylation is reduced to background level,
suggesting that this receptor is inactive. The phosphorylation status of other receptors, e.g. Axl
and EGFR, is not affected by immortalization. The reduced phosphorylation levels of PDGFRA
and PDGFRB correlate with down-regulation of the corresponding genes in the immortalized
cells (Fig 8B). In contrast, IGF-1RmRNA expression was not altered (S11 Fig), while IGF-1R
receptor phosphorylation levels were drastically reduced in imWilms10 cells. In this context it
is interesting that IGF2, one of the ligands for IGF-1R, is the second most down-regulated gene
Fig 7. Down-regulation of the two embryonal growth factors IFG2 andMEST. (A) Down-regulation of
IGF2 in imWilms10 cells cultured at 33°C as seen in two biological replicates on the Agilent array (left). The
down-regulation was confirmed by Q-RT-PCR and is seen when cells are cultured at 33° and 37°C (right).
The error bars correspond to 95% confidence intervals and * corresponds to a significance level of p
0.000001. (B) Down-regulation ofMESTRNA as seen in the two biological replicates (left) and the
confirmation of the protein down-regulation by western blot analysis. The down-regulation is seen at all
temperatures, even at 39°C, the nonpermissive temperature for the tsLT, indicating that it is due to hTERT
expression and is independent on the functional LT.
doi:10.1371/journal.pone.0155561.g007
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in imWilms10 cells (Fig 7A). Thus the absence of IGF2 might be linked to low IGF-1R phos-
phorylation levels in imWilms10 cells.
In summary, our gene expression data show that parental and imWilms10 cells express spe-
cific kidney marker genes at similar levels. In addition Wilms10 cells express genes of diverse
differentiation programs simultaneously, similar to human mesenchymal stem cells (hMSC). A
similarity of Wilms tumor derived cell lines with mutantWT1 to hMSCs was previously
reported by our group [18]. Furthermore, our proteome profiler data show that diverse signal-
ling pathways are active in parental Wilms 10 cells that are efficiently down-regulated during
the process of cell immortalization, suggesting that immortalization is associated with growth
factor independence, an important feature of highly malignant cancer cells.
Differentiation potential of parental Wilms10 and imWilms10 cells
A number of genes involved in osteogenic, adipogenic and muscle differentiation are expressed
at a low level in Wilms10 cells. Therefore, we tested whether parental Wilms10 cells as all other
Fig 8. Human Phospho-RTK array blot and down-regulation of PDGFRA and PDGFRB genes. (A)
Protein extracts fromWilms10 and imWilms10 cells cultured at 33°C were analyzed for the phosphorylation
status of 49 receptors using the ProteomeProfilerTM Phospho-RTK Array kit. Each receptor is spotted in
duplicates. The top blot represents protein analysis of parental Wilms10 cells and the position for the highly
phosphorylated receptors are labelled with their names. Below, the analysis of protein extracts from the
imWilms10 cells. A reduction in the phosphorylation IGF-1R, PDGFRA and PDGFRB receptors is seen,
whereas Axl and EGFR remain unchanged. The strong signals in the left top row, right top row and bottom left
row are positive control spots, indicating that the same amount of protein extracts were analyzed. (B)
Expression intensity of PDGFRA and PDGFRB genes in Wilms10 cells and imWilms10 cultured at 33°C. The
error bar represents the standard error derived from the two biological replicates on the array.
doi:10.1371/journal.pone.0155561.g008
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WT1mutant cells have a differentiation potential for these cell fates. Osteogenic differentiation
was analyzed by Alizarin red staining andWilms10 (S12A and S12B Fig) and imWilms10 cells
were negative. The control hMSC cells were positive (S12C and S12D Fig). Therefore in the
next experiment osteogenic differentiation was measured by calcium deposits as shown in Fig
9A. After 19 days in culture, Wilms10 cells show low levels of calcium compared to hMSC.
Note that uninduced Wilms10 cells also deposit low levels of calcium. The analysis of
imWilms10 in the same experiment and cultured at 37°C, where the tsLT should be partially
inactivated, showed an even lower potential for osteogenic differentiation (Fig 9A). This is not
surprising, as the differentiation process is normally associated with a loss of growth potential.
However, imWilms10 continue to proliferate when differentiation programs are induced.
Moreover, the induction of osteogenic differentiation was not associated with up-regulation of
two genes involved in osteogenesis, BGLAP and ALPL, as measured by Q-RT-PCR after 5 and
10 days of induction (not shown). This indicates that only a few cells have reached a more ter-
minal osteogenic differentiation state and deposit calcium.
To analyze the cells for muscle differentiation we used immunofluorescence with a Titin
antibody. Titin is only produced in different muscle cells [30]. Expression of Titin was seen in
24% of the Wilms 10 cells after 9 days of induction (Fig 9B). In the control culture of human
skeletal myoblasts (HSMM) 24% of the cells were positive for Titin (not shown). The
imWilms10 cells also showed induction of the Titin protein in 10% of the cells (Fig 9B). A few
multinucleated cells were observed in Wilms10 cells by phase contrast already 3 days after
muscle induction (S13 Fig).
Staining of Wilms10 cells with Oil red O after 3 weeks of adipogenic differentiation was neg-
ative (S14A and S14B Fig), whereas control hMSC showed many stained lipid droplets (S14C
and S14D Fig). However, Wilms10 cells acquired a more flattened/cuboidal shape, and their
growth was inhibited (S14E Fig). As Oil red O stains lipid droplets in cells that have reached a
terminal differentiation stage, we analyzed whether the cells are able to express some markers
of adipogenic differentiation. We therefore measured the expression of two adipogenic marker
genes, LPL and PPARG [24] by Q-RT-PCR after 0 and 10 days in adipogenic differentiation
medium. A significant increase in the expression of PPARG but not LPL in comparison to
uninduced control cells was observed in Wilms10 cells, indicating a limited adipogenic differ-
entiation potential (Fig 9C). The analysis of imWilms10 cells also revealed a significant
increase of PPARG expression in comparison to uninduced cells albeit at lower levels than in
parental cells (Fig 9C).
Although for differentiation experiments imWilms10 were cultured at 37°C, their growth
rate was not reduced. The continuous proliferation of imWilms10 cells most likely counter-
acts terminal differentiation in our experiments. To evaluate whether imWilms10 cell prolif-
eration depends on a functional LT, we determined their colony forming ability and their
growth potential at 33°C (permissive temperature), 37°C (semipermissive temperature) and
39°C (nonpermissive temperature). The imWilms10 cells formed large colonies at 37° and
39°C with an efficiency of 77.2% and 80.7% respectively, whereas at 33°C only 39.3% of the
cells formed small colonies (S15 Fig). Similar results were obtained by determining the popu-
lation doubling time of cells cultured at the three temperatures after 11 days in culture. At
33°C the doubling time was 120h, at 37°C 63h and at 39°C 64h. These analyses suggest that
the expression of a functional LT is not necessary for the continuous growth of imWilms 10
cells.
Our differentiation experiments showed that the parental Wilms10 cells have restricted
potentials for muscle, osteogenic and adipogenic differentiation, while these differentiation
potentials are still present in imWilms10, they are even further reduced.
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Fig 9. Differentiation potential of Wilms10 and imWilms10 cell lines. (A) Analysis of osteogenesis as measured
by quantification of calcium production. Parental Wilms10 cells deposit some calcium in the absence of induction
Conditionally ImmortalizedWilms Tumor Cell Line with a HomozygousWT1 Deletion
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Discussion
We describe here a Wilms tumor (Wilms10) with an unusual tumor specific homozygous dele-
tion ofWT1 nested within a heterozygous 11p13 deletion. The 228kb homozygous deletion
only covers theWT1 gene and the 1Mb heterozygous 11p13 deletion extends fromWT1 to
HIPK3. In addition, UPD restricted to 11p15.2pter and including the IGF2 gene was identified,
suggesting a more distal mitotic recombination in 11p15. The high expression of IGF2 in these
cells indicates that the paternal allele was duplicated, whereas the rest of chromosome 11 was
derived from both parental alleles. We have thus identified a Wilms tumor with a complete
lack ofWT1 due to a homozygous deletion. It is highly desirable to establish tumor derived cell
lines to develop cell culture model systems for Wilms tumors with deletedWT1 genes. Thus
our immortalized cell line (imWilms10) represents the first cell culture model system for
Wilms tumors with deletedWT1 genes. The immortalized imWilms10 cells were characterized
by the expression of selected kidney marker genes, by gene expression profiling, DNA analysis
and cell differentiation experiments and were compared to parental Wilms10 cells.
We have previously established a number of cell lines that were derived fromWilms tumors
withWT1mutations. These cell lines harbor two genomic DNA copies of mutantWT1, and all
of them have two copies of chromosome 11 (unpublished observation). In most cases, the
homozygous mutation ofWT1 is due to a mitotic recombination event between the last hetero-
zygous marker in 11q11 and the first homozygous marker in 11p12 (unpublished observation).
The high expression of IGF2 and low expression of H19 in these cell lines indicates that the
paternal allele is duplicated (unpublished observation, BR-P). In one cell line from aWAGR
case with a 11p13 deletion on one allele, the remaining copy ofWT1 carries a mutation, i.e. the
WT1mutation is hemizygous; both paternal chromosome 11 alleles are present in this case
except for the 11p13 deletion. These cell lines express different levels of mutantWT1mRNAs,
whereas Wilms10 cells do not express anyWT1mRNA (see Fig 2). This is an important differ-
ence as mutant WT1 proteins exhibit gain of function properties [10].
Cultured Wilms10 cells harbored a homozygous p.S45Δ CTNNB1mutation due to UPD on
chromosome 3p21pter including CTNNB1. This mutation is different from the one detected in the
primaryWilms10 tumor. The presence of differentCTNNB1mutations supports the sequential lin-
ear model whereby initiating mutations first occur inWT1, and for tumor development, additional
CTNNB1mutations are needed. By microdissection of tumor material and ILNR lesions it has
been observed that various different CTNNB1mutations occur inWT1mutant cells, an example of
genetic heterogeneity inWilms tumor [7, 9] (unpublished observation Uschkereit and BR-P).
Immortalized imWilms10 cells have a stable karyotype and could be propagated at 33° for
extended periods of time and thus can be considered a bona fide cell line. At this stage we have
cultivated imWilms10 cells for 30 passages, corresponding to 90 population doublings. How-
ever, imWilms10 cells also proliferated at 37°C and even at 39°C. The shift of imWilms10 cells
conditions. hMSC cells were used as controls and they show a high level of calcium production after induction of
differentiation. The imWilms10 cells, demonstrate a modest increase of calcium production as compared to parental
Wilms10 cells. (B) Analysis of muscle differentiation by immunofluorescence analysis using a Titin antibody. Left:
Most Wilms10 cells show positive staining for Titin after 9 days of induction. Right: the same analysis was
performed with imWilms10 cells. A lower percentage of cells showed a positive staining for Titin. (C) Quantitative
analysis PPARGmRNA expression, as a marker for adipogenesis. Left: After 10 days of induction a significant
increase is seen in Wiilms10 cells compared to the uninduced control. The expression was normalized versus
RER1 and the analysis was done in triplicates. The error bar corresponds to 95% confidence intervals and *
corresponds to a significance level of p = 0.00001- Right: The same analysis was conducted with imWilms10 cells
and a slightly lower induction was observed when compared to uninduced control cells. Expression analysis was
done after 18 days of induction of imWilms10 cells. The error bar corresponds to 95% confidence intervals and *
corresponds to a significance level of p = 0.00001.
doi:10.1371/journal.pone.0155561.g009
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to the semipermissive temperature 37°C, should result in a partial functional inactivation of
the tsLT. Our gene expression profiling experiments clearly showed that a larger number of
genes are differentially expressed between Wilms10 and imWilms10 cells when these are cul-
tured at the permissive temperature than at the semipermissive temperature (data not shown).
This indicates that the tsLT is indeed functionally temperature sensitive. The complete inacti-
vation of the tsLT occurs at 39°C, but we did not study the cells further at that non-physiologi-
cal temperature. However, a low level of the tsLT protein was detected by Western blot analysis
of imWilms10 cells cultured at 39°C, suggesting that inactivation of the tsLT protein is due to a
conformational effect. Hardy et al., who studied normal human mammary fibroblasts immortal-
ized with telomerase and a tsLT (HMF3A), also detected the tsLT protein at 37° and 39°C by
Western blotting [31]. It is interesting that imWilms10 cells continue to grow at 37°C, whereas,
the HMF3A cells and other normal immortalized cells senesce, when the tsLT is inactivated [12–
17, 31]. We have observed that normal hMSC immortalized with telomerase and the same tsLT
construct did not grow well at 37°C. After prolonged culturing at 39°C, they showed abnormal
muscle differentiation and stopped their growth completely (Görlt and BR-P, unpublished). Two
other immortalizedWilms tumor derived cell lines also continued to grow at the semipermissive
temperature of 37°C (AB, Tenbusch and BR-P, unpublished). This suggests that LT is needed for
the immortalization process but established immortalizedWilms tumor cell lines no longer
depend on a functional LT. This difference to “normal cells” where expression of LT is needed to
keep the cells in an immortalized state is likely due to the fact that these are tumor cells.
In order to study whether the immortalized cells retain biological properties of the parental
Wilms10 cells we first studied the expression of several characteristic kidney marker genes.
Laser capture microdissection of major kidney compartments at mouse embryonic day E15.5
and fluorescence-activated cell sorting of component-specific GFP transgenic mice established
a kidney atlas of gene expression [28]. FoxD1 is highly expressed in cortical and nephrogenic
interstitium, in the same compartment that expressesMeis1 [28]. Expression of Pax3 in meta-
nephric mesenchyme and in the stromal compartment of the developing mouse kidney was
recently demonstrated by immunohistochemistry [29]. Osr1 was shown to identify multi-
potent cells of intermediate mesoderm and its expression becomes restricted during kidney
development to an Osr1-dependent nephron progenitor compartment [32]. The related gene,
Osr2, was also shown to be expressed during kidney development [33]. The Six1 gene plays a
role in limb development and in the developing kidney; it is expressed in uninduced metaneph-
ric mesenchyme at E10.5 and in induced mesenchyme at E11.5 [34]. Furthermore, SIX1 pro-
tein expression was shown in the blastemal elements of Wilms tumors [35]. These
characteristic genes are expressed in allWT1mutant cell lines and Wilms10 cells and are unal-
tered in imWilms10 cells. This indicates that theseWT1mutant cells may correspond to an
early stage of kidney development before specification of the different lineages and the
imWilms10 cells have retained these properties. In addition other genes expressed in kidney
cells such as SNPO, CD2AP and NES are not changed by the immortalization process.
One major difference between the Wilms10 cells and imWilms10 cells is the up-regulation
of cell cycle genes caused by the expression of hTERT and the tsLT. Another difference is their
state of signaling pathways. Paternal Wilms10 cells showed activation of several signaling path-
ways, i.e. PDGFR, EGFR, IGF and AXL as revealed by proteome profiler antibody arrays. Upon
immortalization, these cells show a down-regulation as well as functional inactivation of several
enzyme-linked receptors (RTK). In the case of PDGFRA and PDGFRB decreased phosphoryla-
tion is linked to a down-regulation of mRNA expression. In contrast, down-regulation of
IGF1R phosphorylation was observed with unchanged IGF1R gene expression levels. As phos-
phorylation of this receptor is triggered by ligand binding, the almost complete down-regula-
tion of IGF2 gene expression in imWilms10 cells might explain this finding. It is interesting
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that besides IGF2, expression of another fetal growth factor (MEST), is also reduced to basal
levels after immortalization. The down-regulation of IGF2 in imWilms10 cells is remarkable in
the context of the paternal duplication of chromosome 11p15 and expression of the gene from
both alleles. The down-regulation IGF2 andMEST expression occurs at permissive and non-
permissive temperatures and is therefore independent of tsLT. It therefore likely that telome-
rase is linked to IGF2 andMEST gene down-regulation in imWilms10 cells, as a function of
telomerase in overall chromatin structure regulation and epigenetic mechanisms has been
described [36]. Note that telomerase expression in bovine adrenocortical cells is correlated
with an induction of IGF2 expression [37], whereas it is associated with a repression of IGF2
expression in immortalized Wilms tumor cells. This observation suggests that the effect of telo-
merase is highly cell context dependent and that the expression of fetal growth factors in
embryonal Wilms tumor cells is not compatible with the establishment of immortalized cells
with an unlimited life span. In summary, the immortalized Wilms tumor cells can proliferate
despite a down-regulation of ligands and receptors for several signaling pathways. It will be of
interest to study the mechanisms that lead to the activation of these different signaling path-
ways in the parental Wilms tumor cells and the effects of their down-regulation on the growth
of these cells. This should be kept in mind when novel therapeutic approaches targeting of one
of these signaling pathways are considered, as the others can still be activated [38]. However, a
reduction of tumor growth was observed in mice treated with a specific inhibitor for IGF1R. In
this case, the tumor was established by orthotopically injecting Wilms tumor cells with elevated
IGF1R signaling but without aWT1mutation in the kidney of mice [39]. Therefore more basic
experimental studies using different Wilms tumor cell lines are needed to develop individual-
ized therapies targeting specific activated signaling pathways.
The primary Wilms10 tumor cells show a limited multilineage differentiation potential for
osteogenesis, adipogenesis and muscle differentiation, similar to the otherWT1mutant cells.
The derived immortalized cells have retained these properties although at a reduced capacity,
likely due to the fact that they continue to grow at 37°C, which is not compatible with differen-
tiation. Therefore the parental Wilms tumor cell line with a novel and unusual chromosome 11
alteration and the immortalized derivative with a homozygous deletion of the entireWT1 gene
will be useful for further studies on the function of WT1 in Wilms tumor development, to fur-
ther explore the origin ofWT1mutant tumors as well as for the analysis of activated signaling
pathways. Last not least these cells are valuable as negative controls to test various batches of
WT1 antibodies, that are known for their unspecific cross reactivity with many proteins.
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